Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease

Neuroscience

Volumn 97, Issue 1, 2000, Pages 79-88

  Orieux, G ^a   Francois, C ^a   Feger J ^a   Yelnik, J ^a   Vila, M ^a   Ruberg, M ^a   Agid, Y ^a   Hirsch, E C ^a  

^a INSERM   (France)

Author keywords

6 OHDA lesioned rats; Cytochrome oxidase; Parafascicular nucleus; Pedunculopontine nucleus; Retrograde tracing; Subthalamic nucleus

Indexed keywords

CYTOCHROME C OXIDASE; MARKER; MESSENGER RNA; OXIDOPAMINE; WHEAT GERM AGGLUTININ HORSERADISH PEROXIDASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN NUCLEUS; CELL ACTIVITY; CELL METABOLISM; CONTROLLED STUDY; DENERVATION; DOPAMINERGIC SYSTEM; ENZYME SUBUNIT; GLOBUS PALLIDUS; IN SITU HYBRIDIZATION; MALE; NERVE CELL STIMULATION; NERVE PROJECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PEDUNCULOPONTINE NUCLEUS; PRIORITY JOURNAL; RAPHE NUCLEUS; RAT; RETROGRADE NERVE FIBER TRANSPORT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS PARAFASCICULAR NUCLEUS;

ANIMALS; AXONAL TRANSPORT; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; EXCITATORY POSTSYNAPTIC POTENTIALS; INTRALAMINAR THALAMIC NUCLEI; MALE; NERVE DEGENERATION; NEURAL PATHWAYS; NEURONS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PONS; RATS; RATS, SPRAGUE-DAWLEY; SUBTHALAMIC NUCLEUS;

EID: 0034044957     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00011-7     Document Type: Article

References (71)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. Anglade P., Tsuji S., Javoy-Agid F., Agid Y., Hirsch E.C. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease. Ann. Neurol. 37:1995;265-272.
3. Bell K., Churchill L., Kalivas P.W. GABAergic projection from the ventral pallidum and globus pallidus to the subthalamic nucleus. Synapse. 20:1995;10-18.
4. Benazzouz A., Gross C., Féger J., Boraud T., Bioulac B. Reversal of rigidity and improvement of motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci. 5:1993;382-389.
5. Beninato M., Spencer R.F. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res. 412:1987;169-174.
6. Bergman H., Wichmann T., DeLong M.R. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science. 249:1990;1436-1438.
7. Bergman H., Wichmann T., Karmon B., DeLong M.R. The primate subthalamic nucleus. 2. Neuronal activity in the MPTP model of Parkinsonism. J. Neurophysiol. 72:1994;507-520.
8. Bevan M.D., Bolam J. Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat. J. Neurosci. 15:1995;7105-7120.
9. Bevan M.D., Francis C.M., Bolam J.P. The glutamate-enriched cortical and thalamic input to neurons in the subthalamic nucleus of the rat: convergence with GABA-positive terminals. J. comp. Neurol. 361:1995;491-511.
10. Blandini F., Garcia-Osuna M., Greenamyre J.T. Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats. Eur. J. Neurosci. 9:1997;1407-1413.
11. Canteras N.S., Shammah-Lagnado S.J., Silva B.A., Ricardo J.A. Somatosensory inputs to the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 458:1988;53-64.
12. Canteras N.S., Shammah-Lagnado S.J., Silva B.A., Ricardo J.A. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513:1990;43-59.
13. Carlson J., Pearlstein R., Bucholz J., Iacono R.P., Maeda G. Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's models rats. Brain Res. 828:1999;12-19.
14. Clarke N.P., Bevan M.D., Cozzari C., Hartman B.K., Bolam J.P. Glutamate-enriched cholinergic synaptic terminals in the entopeduncular nucleus and subthalamic nucleus of the rat. Neuroscience. 81:1997;371-385.
15. Delfs J.M., Ciaramitaro V.M., Parry T.J., Chesselet M.F. Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. J. Neurosci. 15:1995;6562-6575.
16. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
17. Deschênes M., Bourassa J., Doan V.D., Parent A. A single-cell study of the axonal projections arising from the posterior intralaminar thalamic nuclei in the rat. Eur. J. Neurosci. 8:1996;329-343.
18. Engber T.M., Papa S.M., Boldry R.C., Chase T.N. NMDA receptor blockade reverses motor response alterations induced by levodopa. NeuroReport. 5:1994;2586-2588.
19. Feger J., Bevan M., Crossman A.R. The projections from the parafascicular thalamic nucleus to the subthalamic nucleus and the striatum arise from separate neuronal populations: a comparison with the corticostriatal and corticosubthalamic afferents in a retrograde fluorescent double-labelling study. Neuroscience. 60:1994;125-132.
20. Feger J., Hammond C., Rouzaire-Dubois B. Pharmacological properties of acetylcholine-induced excitation of subthalamic nucleus neurones. Br. J. Pharmac. 65:1979;511-515.
21. Filion M., Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res. 547:1991;142-151.
22. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. A. Rev. Neurosci. 15:1992;285-320.
23. Greenamyre J.T., Eller R.V., Zhang Z., Ovadia A., Kurlan R., Gash D.M. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann. Neurol. 35:1994;655-661.
24. Guridi J., Herrero M.T., Luquin M.R., Guillen M., Ruberg M., Laguna J., Vila M., Javoy-Agid F., Agid Y., Hirsch E., Obeso J.A. Subthalamotomy in parkinsonian monkeys. Brain. 119:1996;1717-1727.
25. Hammond C., Rouzaire-Dubois B., Féger J., Jackson A., Crossman A.R. Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat. Neuroscience. 9:1983;41-52.
26. Hassani O.K., Francois C., Yelnik J., Feger J. Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. Brain Res. 749:1997;88-94.
27. Hassani O.K., Mouroux M., Féger J. Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus. Neuroscience. 72:1996;105-115.
28. Herrero M.T., Levy R., Ruberg M., Luquin M.R., Villares J., Guillen J., Faucheux B., Javoy-Agid F., Guridi J., Agid Y., Obeso J.A., Hirsch E.C. Consequences of nigrostriatal denervation and L-dopa therapy on the expression of the glutamic acid decarboxylase messenger RNA in the pallidum. Neurology. 47:1996;219-224.
29. Hevner R.F., Wong-Riley M.T. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J. Neurosci. 11:1991;1942-1958.
30. Hevner R.F., Wong-Riley M.T. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J. Neurosci. 13:1993;1805-1819.
31. Hollerman J.R., Grace A.A. Subthalamic nucleus cell firing in the 6-OHDA-treated rat: basal activity and response to haloperidol. Brain Res. 590:1992;291-299.
32. Hutchison W.D., Allan R.J., Opitz H., Levy R., Dostrovsky J.O., Lang A.E., Lozano A.M. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann. Neurol. 44:1998;622-628.
33. Jackson A., Crossman A.R. Nucleus tegmenti pedunculopontinus: efferent connections with special reference to the basal ganglia, studied in the rat by anterograde and retrograde transport of horseradish peroxidase. Neuroscience. 10:1983;725-765.
34. Kawaguchi Y., Wilson C.J., Emson P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10:1990;3421-3438.
35. Kincaid A.E., Albin R.L., Newman S.W., Penney J.B., Young A.B. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience. 51:1992;705-718.
36. Kitai S.T., Deniau J.M. Cortical inputs to the subthalamus: intracellular analysis. Brain Res. 214:1981;411-415.
37. Klockgether T., Turski L. NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann. Neurol. 28:1990;539-546.
38. Kolmac C.I., Power B.D., Mitrofanis J. Patterns of connections between zona incerta and brainstem in rats. J. comp. Neurol. 396:1998;544-555.
39. Lavoie B., Parent A. Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods. J. comp. Neurol. 344:1994;210-231.
40. Levy R., Hazrati L.N., Herrero M.T., Vila M., Hassani O.K., Mouroux M., Ruberg M., Asensi H., Agid Y., Feger J., Obeso J.A., Parent A., Hirsch E.C. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience. 76:1997;335-343.
41. Limousin P., Pollak P., Benazzouz A., Hoffmann D., Le Bas J.F., Broussolle E., Perret J.E., Benabid A.L. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
42. Loschmann P.A., Lange K.W., Kunow M., Rettig K.J., Jahnig P., Honore T., Turski L., Wachtel H., Jenner P., Marsden C.D. Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-dopa in models of Parkinson's disease. J. neural Transm. 3:1991;203-213.
43. Maj J., Skuza G., Rogoz Z. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity. J. neural Transm. 6:1993;53-62.
44. Maurice N., Deniau J.M., Glowinski J., Thierry A.M. Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the corticosubthalamic circuits. J. Neurosci. 18:1998;9539-9546.
45. Maurice N., Deniau J.M., Menetrey A., Glowinski J., Thierry A.M. Prefrontal cortex-basal ganglia circuits in the rat: involvement of ventral pallidum and subthalamic nucleus. Synapse. 29:1998;363-370.
46. Mesulam M.M. Tetramethyl benzidine for horseradish peroxidase neurohistochemistry: a non-carcinogenic blue reaction-product with superior sensitivity for visualizing neural afferents and efferents. J. histochem. Cytochem. 26:1978;106-117.
47. Miller W. and DeLong M. R. (1987) Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In The Basal Ganglia II (eds Carpenter M. B. and Jayraman A.), pp. 414-427. Plenum, New York.
48. Mouroux M., Feger J. Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic. NeuroReport. 4:1993;613-615.
49. Mouroux M., Hassani O.K., Féger J. Electrophysiological study of the excitatory parafascicular projection to the subthalamic nucleus and evidence for ipsi- and contralateral controls. Neuroscience. 67:1995;399-407.
50. Naudon L., Raisman-Vozari R., Edwards R.H., Leroux-Nicollet I., Peter D., Liu Y., Costentin J. Reserpine affects differentially the density of the vesicular monoamine transporter and dihydrotetrabenazine binding sites. Eur. J. Neurosci. 8:1996;842-846.
51. Pan H.S., Walters J.R. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat. Synapse. 2:1988;650-656.
52. Papa S.M., Chase T.N. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann. Neurol. 39:1996;574-578.
53. Paxinos G and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, Sydney.
54. Peschanski M., Besson J.M. Diencephalic connections of the raphe nuclei of the rat brainstem: an anatomical study with reference to the somatosensory system. J. comp. Neurol. 224:1984;509-534.
55. Rinvik E, Grofova I, Hammond C, Féger J and Deniau JM. (1979) A study of the afferent connections to the subthalamic nucleus in the monkey and the cat using the HRP Technique. Raven, New York.
56. Robledo P., Féger J. Acute monoaminergic depletion in the rat potentiates the excitatory effect of the subthalamic nucleus in the substantia nigra pars reticulata but not in the pallidal complex. J. neural Transm. 86:1991;115-126.
57. Roger M., Cadusseau J. Afferents to the zona incerta in the rat: a combined retrograde and anterograde study. J. comp. Neurol. 241:1985;480-492.
58. Shink E., Bevan M.D., Bolam J.P., Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience. 73:1996;335-357.
59. Smith Y., Bolam J.P., Von Krosigk M. Topographical and synaptic organization of the GABA-containing pallidosubthalamic projection in the rat. Eur. J. Neurosci. 2:1990;500-511.
60. Soghomonian J.J., Chesselet M.F. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse. 11:1992;124-133.
61. Starr M.S., Starr B.S., Kaur S. Stimulation of basal and L-DOPA-induced motor activity by glutamate antagonists in animal models of Parkinson's disease. Neurosci. Biobehav. Rev. 21:1997;437-446.
62. Sugimoto T., Hattori T., Mizuno N., Itoh K., Sato M. Direct projections from the centre median-parafascicular complex to the subthalamic nucleus in the cat and rat. J. comp. Neurol. 214:1983;209-216.
63. Takakusaki K., Shiroyama T., Kitai S.T. Two types of cholinergic neurons in the rat tegmental pedunculopontine nucleus: electrophysiological and morphological characterization. Neuroscience. 79:1997;1089-1109.
64. Takakusaki K., Shiroyama T., Yamamoto T., Kitai S.T. Cholinergic and noncholinergic tegmental pedunculopontine projection neurons in rats revealed by intracellular labeling. J. comp. Neurol. 371:1996;345-361.
65. Van Der Kooy D., Hattori T., Shannak K., Hornykiewicz O. The pallido-subthalamic projection in rat: anatomical and biochemical studies. Brain Res. 204:1981;253-268.
66. Verhagen M.L., Del Dotto P., Blanchet P.J., van den Munckhof P., Chase T.N. Blockade of glutamatergic transmission as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Amino Acids. 14:1998;75-82.
67. Vila M., Levy R., Herrero M.T., Faucheux B., Obeso J.A., Agid Y., Hirsch E.C. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. Neuroscience. 71:1996;903-912.
68. Vila M., Levy R., Herrero M.T., Ruberg M., Faucheux B., Obeso J.A., Agid Y., Hirsch E.C. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J. Neurosci. 17:(2):1997;765-773.
69. Vila M., Marin C., Ruberg M., Bonastre M., Raisman-Vozari R., Agid Y., Tolosa E., Hirsch E.C. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia. J. Neurochem. 73:1999;344-352.
70. Wong-Riley M.T. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci. 12:1989;94-101.
71. Woolf N.J., Butcher L.L. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res. Bull. 16:1986;603-637.